Yuji Mukai

Novel high-performance liquid chromatography–tandem mass spectrometry method for simultaneous quantification of BCR-ABL and Bruton’s tyrosine kinase inhibitors and their three active metabolites in human plasma

Yuji Mukai, Tatsunari Yoshida, Takeshi Kondo et al. · Journal of Chromatography B · 2019 · 32 citations

Medicine, Pharmacokinetics, Pharmacology +17

Angiotensin II Receptor Blockers Inhibit the Generation of Epoxyeicosatrienoic Acid from Arachidonic Acid in Recombinant<scp>CYP</scp>2C9,<scp>CYP</scp>2J2 and Human Liver Microsomes

Asuna Senda, Yuji Mukai, Tõru Hayakawa et al. · Basic & Clinical Pharmacology & Toxicology · 2017 · 18 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Effects of Angiotensin II Receptor Blockers on Metabolism of Arachidonic Acid &lt;i&gt;via&lt;/i&gt; CYP2C8

Asuna Senda, Yuji Mukai, Takaki Toda et al. · Biological and Pharmaceutical Bulletin · 2015 · 12 citations · Full text

Medicine, Cardiology, Pharmacology +17

The Inhibitory Effect of Telmisartan on the Metabolism of Arachidonic Acid by CYP2C9 and CYP2C8: An &lt;i&gt;in Vitro&lt;/i&gt; Study

Yuka Kato, Yuji Mukai, Anders Rane et al. · Biological and Pharmaceutical Bulletin · 2017 · 12 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Drug−drug Interaction between Losartan and Paclitaxel in Human Liver Microsomes with Different<scp>CYP</scp>2C8 Genotypes

Yuji Mukai, Asuna Senda, Takaki Toda et al. · Basic & Clinical Pharmacology & Toxicology · 2014 · 11 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17